In 2023, hospital discharges for carcinoma in situ in France stood at approximately 11.50 thousand. Forecasted data from 2024 to 2028 indicate a declining trend, with values decreasing from 11.15 thousand in 2024 to 9.84 thousand in 2028. Year-on-year percentage variations are notable, demonstrating a consistent decline at an average CAGR of about 2.3% across this five-year period.

Future trends to watch for include:

An increased emphasis on early detection and preventive measures, which may contribute to reduced hospital discharges.
Potential policy changes in healthcare that could either improve outpatient management or impact hospitalization rates.
Technological advancements in early diagnosis and minimally invasive treatment approaches reducing the need for hospital stays.